China Pharma Holdings, Inc.CPHINYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P18
Within normal range
vs 3Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -181.42% |
| Q2 2025 | 603.41% |
| Q1 2025 | -124.25% |
| Q4 2024 | 607.91% |
| Q3 2024 | 35.44% |
| Q2 2024 | 87.57% |
| Q1 2024 | -2521.32% |
| Q4 2023 | -102.22% |
| Q3 2023 | 565.40% |
| Q2 2023 | 85.26% |
| Q1 2023 | -351.15% |
| Q4 2022 | 166.79% |
| Q3 2022 | 165.64% |
| Q2 2022 | 62.04% |
| Q1 2022 | -343.91% |
| Q4 2021 | 56.06% |
| Q3 2021 | -166.69% |
| Q2 2021 | 344.13% |
| Q1 2021 | -182.33% |
| Q4 2020 | 249.90% |
| Q3 2020 | -345.46% |
| Q2 2020 | 119.44% |
| Q1 2020 | 40.86% |
| Q4 2019 | -268.55% |
| Q3 2019 | -43.91% |
| Q2 2019 | 829.35% |
| Q1 2019 | -63.69% |
| Q4 2018 | -71.78% |
| Q3 2018 | 321.19% |
| Q2 2018 | -176.25% |
| Q1 2018 | -44.09% |
| Q4 2017 | 38.16% |
| Q3 2017 | 186.56% |
| Q2 2017 | -8122.76% |
| Q1 2017 | -99.34% |
| Q4 2016 | 70.04% |
| Q3 2016 | 215.84% |
| Q2 2016 | -157.42% |
| Q1 2016 | -51.70% |
| Q4 2015 | 131.06% |